Company Overview of OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. develops and produces bio-based chemicals and fuels. It offers bioacrylic, a sustainable and affordable direct replacement for petro-acrylic; and fatty acids and derivatives. The company has strategic partnerships with The Dow Chemical Company, Evonik, and Johnson Matthey. OPX Biotechnologies, Inc. was founded in 2007 and is based in Boulder, Colorado. As of April 28, 2015, OPX Biotechnologies, Inc. operates as a subsidiary of Cargill, Incorporated.
2425 55th Street
Boulder, CO 80301
Founded in 2007
Key Executives for OPX Biotechnologies, Inc.
OPX Biotechnologies, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|10x Technology LLC||United States|
|20/20 Custom Molded Plastics,Ltd.||United States|
|21st Century Plastics Corporation||United States|
|2N2, Inc.||United States|
|6062 Holdings, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|Bloomberg L.P.||United States|
|NYC2012, Inc.||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact OPX Biotechnologies, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.